Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
7,550,163
-
Share change
-
+1,262,426
-
Total reported value
-
$143,830,000
-
Price per share
-
$19.05
-
Number of holders
-
18
-
Value change
-
+$24,085,212
-
Number of buys
-
7
-
Number of sells
-
8
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q3 2020
As of 30 Sep 2020,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,550,163 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Point72 Asset Management, L.P., Atlas Venture Advisors, Inc., SAMLYN CAPITAL, LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, Laurion Capital Management LP, and Verition Fund Management LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.